People of Action, Building the Future of Gene Therapy

We believe in progress measured by results — not promises.

OncoSwitch is a team of scientists and engineers creating AI-programmable DNA switches for selective, safe, and adaptive gene therapy.

We combine artificial intelligence with molecular biology to make treatment smarter and safer for every patient.

Our Story

Why We Started

Every person knows someone affected by cancer — and we believe treatment should not affect the whole body.

OncoSwitch was born from a simple idea: therapy should be smart enough to activate only where it’s needed, remaining silent in healthy tissue.

Our approach isn’t about loud promises or buzzwords — it’s about consistent, reproducible progress. We focus on measurable results and clear milestones that bring us closer to safer therapy options.

Our Philosophy

We Choose Meaning Over Noise

We don’t trade in slides — we build working systems that can be trusted.

Every failure strengthens the platform and improves the dataset.

Our product map openly shows results, deadlines, and verification steps.

Transparency, reproducibility, and measurable progress are the foundation of everything we do.

Vision & Mission

Vision

The design of regulatory DNA sequences becomes an industry standard — switches that turn therapy on only where needed.

Mission

Provide biotech and pharma partners with a closed-loop AI-biology platform: design → test (MPRA) → training → redesign → validation.

How We Work

A Platform That Learns From Every Experiment

We use MPRA (Massive Parallel Reporter Assays) to test thousands of DNA sequences in parallel.
The data is fed back into an AI model that learns to predict and improve performance — creating a self-improving system.
Each cycle generates new data, better models, and safer switches — continuously refining our platform.